Literature DB >> 20496133

The role of surgery in the treatment of neuroblastoma.

Masayuki Kubota1.   

Abstract

The role of surgery varies greatly according to the clinical condition of the patients with neuroblastoma. A surgical resection is the mainstay of treatment for a localized tumor. However, in the era of intense chemotherapy associated with hematopoietic stem cell plant rescue, surgical resections are recommended without sacrificing the kidney or major vessels. Tumor biology further defines the necessity of supportive chemotherapy or radiation after surgical resection. The presence of diverse terminology concerning the range of resection may impose some confusion in the understanding of the previous papers. Therefore, the definition of a surgical resection was initially stated. In high-risk patients, the advantages of surgery for a patient's survival seem to be limited. This article reviews the efficacy of surgical resections in different clinical situations for a better understanding of the meaning of surgery in the treatment of neuroblastoma. The results of surgical resections are summarized according to the International Neuroblastoma Staging System. Finally, the long-term results regarding the strategy-related survival of the patients in the Niigata tumor board are briefly introduced.

Entities:  

Mesh:

Year:  2010        PMID: 20496133     DOI: 10.1007/s00595-009-4092-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  33 in total

1.  Spontaneous regression of neuroblastoma detected by mass screening.

Authors:  M Matsumura; A Tsunoda; T Nishi; H Nishihira; Y Sasaki
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

2.  Radical surgery for abdominal neuroblastoma.

Authors:  E M Kiely
Journal:  Semin Surg Oncol       Date:  1993 Nov-Dec

3.  Treatment complications in children diagnosed with neuroblastoma during a screening program.

Authors:  Stéphane Barrette; Mark L Bernstein; Jean-Marie Leclerc; Martin A Champagne; Yvan Samson; Josée Brossard; William G Woods
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

4.  Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma.

Authors:  Chee-Chee Koh; Jin-Cherng Sheu; Der-Cherng Liang; Shu-Huey Chen; Hsi-Che Liu
Journal:  Pediatr Surg Int       Date:  2005-01-13       Impact factor: 1.827

5.  Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy.

Authors:  Andrew M Davidoff; Bethany L Corey; Fredric A Hoffer; Victor M Santana; Wayne L Furman; Stephen J Shochat
Journal:  Pediatr Blood Cancer       Date:  2005-02       Impact factor: 3.167

6.  Is surgery necessary for incidentally discovered adrenal masses in children?

Authors:  Peter T Masiakos; J Ted Gerstle; Timothy Cheang; Sandra Viero; Peter C W Kim; Paul Wales
Journal:  J Pediatr Surg       Date:  2004-05       Impact factor: 2.545

7.  Fetal and neonatal neuroblastoma: retrospective review of 271 cases.

Authors:  Hart Isaacs
Journal:  Fetal Pediatr Pathol       Date:  2007 Jul-Aug       Impact factor: 0.958

8.  The impact of surgical radicality on outcome in childhood neuroblastoma.

Authors:  D von Schweinitz; B Hero; F Berthold
Journal:  Eur J Pediatr Surg       Date:  2002-12       Impact factor: 2.191

9.  Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.

Authors:  Juan C Gutierrez; Anne C Fischer; Juan E Sola; Eduardo A Perez; Leonidas G Koniaris
Journal:  Pediatr Surg Int       Date:  2007-05-03       Impact factor: 2.003

10.  Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

Authors:  B De Bernardi; V Mosseri; H Rubie; V Castel; A Foot; R Ladenstein; G Laureys; M Beck-Popovic; A F de Lacerda; A D J Pearson; J De Kraker; P F Ambros; Y de Rycke; M Conte; P Bruzzi; J Michon
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more
  6 in total

1.  Ultrasound-guided core needle biopsy in the diagnosis of neuroblastic tumors in children: a retrospective study on 83 cases.

Authors:  Lihui Zhao; Jie Mu; Ping Du; Hailing Wang; Yiran Mao; Yong Xu; Xiaojie Xin; Fenglin Zang
Journal:  Pediatr Surg Int       Date:  2016-12-18       Impact factor: 1.827

2.  Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution.

Authors:  Tatsuro Tajiri; Ryota Souzaki; Yoshiaki Kinoshita; Yuhki Koga; Aiko Suminoe; Toshiro Hara; Tomoaki Taguchi
Journal:  Surg Today       Date:  2012-01-19       Impact factor: 2.549

Review 3.  Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95 % tumour resection suffice?

Authors:  S Zwaveling; G A M Tytgat; D C van der Zee; M H W A Wijnen; H A Heij
Journal:  Pediatr Surg Int       Date:  2012-06-22       Impact factor: 1.827

4.  DO THE RADIOLOGICAL CRITERIA WITH THE USE OF RISK FACTORS IMPACT THE FORECASTING OF ABDOMINAL NEUROBLASTIC TUMOR RESECTION IN CHILDREN?

Authors:  Ana Cláudia Soares Penazzi; Vivian Siqueira Tostes; Alexandre Alberto Barros Duarte; Henrique Manoel Lederman; Eliana Maria Monteiro Caran; Simone de Campos Vieira Abib
Journal:  Arq Bras Cir Dig       Date:  2017 Apr-Jun

Review 5.  Advances in the Surgical Treatment of Neuroblastoma.

Authors:  Yan-Bing Luo; Xi-Chun Cui; Lin Yang; Da Zhang; Jia-Xiang Wang
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

6.  Role of image-defined risk factors in predicting surgical complications of localized neuroblastoma.

Authors:  Tao Liu; Zhibao Lv; Weijue Xu; Jiangbin Liu; Qingfeng Sheng
Journal:  Pediatr Surg Int       Date:  2020-08-26       Impact factor: 1.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.